Effect of a Lactocare, on gut microbs in critically ill septic patients admitted to intensive care units

Effect of a probiotic supplementation, Lactocare, on gut microbiota in critically ill septic patients admitted to intensive care units

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20091012002582N19

Enrollment

Registered

2018-05-09

Start date

2018-06-22

Completion date

Unknown

Last updated

2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Other infectious diseases. Other infectious disease

Interventions

Intervention 1: Intervention group: En All patients in intervention group will receive enteral capsules of Lactocare (1 capsule/12h) for 10 days in addition to standard ICU treatment. Intervention 2:

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Need for enteral nutrition Age over 18 years old Age under 70 years old

Exclusion criteria

Exclusion criteria: age under 18 years old age over 70 years old pregnancy lactating previous history of lactocare use Long-term administration of systemic corticosteroid History of alcohol consumption History of intestinal surgery in a recent month

Design outcomes

Primary

Measure	Time frame
Gut microbiota in critically ill septic patients admitted to intensive care units. Timepoint: En days 1th and 10th. Method of measurement: PCR of stool.	—

Secondary

Measure	Time frame
En ICU length of stay. Timepoint: En during ICU stay. Method of measurement: En days that patient is stayed in ICU.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAta Mahmoodpoor

Tabriz University of Medical Sciences

mahmoodpoora@tbzmed.ac.ir+98 41 3332 8009

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026